Phenelzine

This classification denotes a monoamine oxidase inhibitor and antidepressant agent with the molecular formula C8H12N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O408N561GF, chemically known as hydrazine, phenethyl-, monohydrochloride but generally known as phenelzine, which bears US NIH Compound Identifier 3675. European Medicines Agency schedules Phenelzine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09757MIG. The term PHENELZINE is an International Non-Proprietary Name. World Health Organization schedules phenelzine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENELZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenelzine under HS 29280090 and SITC 51486. As of Q4 2014, PHENELZINE remains the US FDA Preferred Term for this commodity. Phenelzine bears US NLM identifiers UMLS ID C0031392 and NCI Concept Code C61888. SMILES: N(N)CCc1ccccc1.